Joël Claveau, Université Laval

Research

Read how they describe their research on their Université Laval profile.

Latest papers

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.
Journal for immunotherapy of cancer · 2021

All 1 publications

Latest funding

Studying risk factors and striving to increase the efficacy of prevention programs for cutaneous melanoma in Canada.
CIHR · 2019 · Co-investigator
$93,900

All 1 grants and awards

1 publications.

01

Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.

Slingluff CL, Lewis KD, Andtbacka R, Hyngstrom J, Milhem M, Markovic SN, Bowles T, Hamid O, Hernandez-Aya L, Claveau J, Jang S, Philips P, Holtan SG, Shaheen MF, Curti B, Schmidt W, Butler MO, Paramo J, Lutzky J, Padmanabhan A, Thomas S, Milton D, Pecora A, Sato T, Hsueh E, Badarinath S, Keech J, Kalmadi S, Kumar P, Weber R, Levine E, Berger A, Bar A, Beck JT, Travers JB, Mihalcioiu C, Gastman B, Beitsch P, Rapisuwon S, Glaspy J, McCarron EC, Gupta V, Behl D, Blumenstein B, Peterkin JJ

Journal for immunotherapy of cancer202119 citationsOpen Access

DOI: 10.1136/jitc-2021-003272 PMID: 34599031

Studying risk factors and striving to increase the efficacy of prevention programs for cutaneous melanoma in Canada.

Co-investigatorCIHR2019Cat Gr: Disease Prev./Risk Factor Mod.- Non-communicable diseases for Indigenous

Principal investigators: Litvinov, Ivan V; Andrews-Clay, Kathryn

Keywords: Behaviour Modification; First Nation Cummunities; Melanoma; Occupational Exposure; Patient Education; Prevention; Primary Prevention; Risk Awareness; Risk Factors; Sun Exposure

$93,900

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Catalin Mihalcioiu

Department of Medicine

1 shared papers, latest 2021

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Subject: Prospective PhD student Dear Professor Claveau, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence." (2021), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]